Novartis Ag (NVS) Gross Profit (2009 - 2026)
Novartis Ag's Gross Profit was $11.24 billion in Q2 2026, down 2.4% from $11.51 billion a year earlier but up 11.7% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Gross Profit (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Novartis Ag's Gross Profit was $42.37 billion through Jun 30, 2026, up 0.7% year-over-year; for FY2025, it was $42.98 billion, up 10.5% from FY2024.
- Gross Profit has now increased for three consecutive years, with a five-year compound annual growth rate of 4.3% (FY2020 to FY2025).
- In earlier years, Gross Profit was $38.9 billion in FY2024 (+13.8%), $34.19 billion in FY2023 (+7.2%), $31.88 billion in FY2022 (-1.1%) and $32.24 billion in FY2021 (-7.3%).
- Quarterly Gross Profit has moved between $7.91 billion (Q3 2022) and $11.51 billion (Q2 2025) over five years.
- Compared with a year earlier, Gross Profit was higher in six of the last eight quarters, with growth averaging 8.1%.
- The best year-over-year quarter for Gross Profit over five years was Q2 2025 (growth of 18.7%); the worst was Q4 2022 (a decline of 17.0%).
- Per Business Quant data, NVS's Gross Profit in the three quarters before Q2 2026 was $10.07 billion (Q1 2026), $10.25 billion (Q4 2025) and $10.82 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.24 Bn |
| Mar 31, 2026 | 10.07 Bn |
| Dec 31, 2025 | 10.25 Bn |
| Sep 30, 2025 | 10.82 Bn |
| Jun 30, 2025 | 11.51 Bn |
| Mar 31, 2025 | 10.39 Bn |
| Dec 31, 2024 | 10.23 Bn |
| Sep 30, 2024 | 9.94 Bn |
| Jun 30, 2024 | 9.70 Bn |
| Mar 31, 2024 | 9.02 Bn |
| Dec 31, 2023 | 8.75 Bn |
| Sep 30, 2023 | 8.98 Bn |
| Jun 30, 2023 | 8.40 Bn |
| Mar 31, 2023 | 8.06 Bn |
| Dec 31, 2022 | 7.93 Bn |
| Sep 30, 2022 | 7.91 Bn |
| Jun 30, 2022 | 9.33 Bn |
| Mar 31, 2022 | 8.96 Bn |
| Dec 31, 2021 | 9.55 Bn |
| Sep 30, 2021 | 9.43 Bn |
API Access
Novartis Ag Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();